{
    "medicine_id": "e64cfb440bf0eae37b3fe7ef25f8571d55ac2d07",
    "platform_id": "DB06723",
    "metadata": {
        "name": "Acid Gone Antacid 0 6 g Suspension",
        "composition": "0 6 g Aluminum hydroxide",
        "clinical_particulars": {
            "therapeutic_indications": "For relief of heartburn and acid indigestion",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Gastric peptic disease occurs as a result of an imbalance between protective factors such as mucus bicarbonate and prostaglandin secretion and aggressive factors such as hydrochloric acid pepsin and Helicobacter pylori H pylori Antacids work by restoring acid base balance attenuating the pepsin activity and increasing bicarbonate and prostaglandin secretion",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00126",
                        "description": "Ascorbic acid can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00146",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcifediol"
                    },
                    {
                        "drugbank-id": "DB00153",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Ergocalciferol"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00910",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01070",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Dihydrotachysterol"
                    },
                    {
                        "drugbank-id": "DB01436",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Alfacalcidol"
                    },
                    {
                        "drugbank-id": "DB04258",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Seocalcitol"
                    },
                    {
                        "drugbank-id": "DB04796",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Inecalcitol"
                    },
                    {
                        "drugbank-id": "DB04891",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Becocalcidiol"
                    },
                    {
                        "drugbank-id": "DB05295",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Eldecalcitol"
                    },
                    {
                        "drugbank-id": "DB06117",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with 1alpha 24S Dihydroxyvitamin D2"
                    },
                    {
                        "drugbank-id": "DB06194",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Elocalcitol"
                    },
                    {
                        "drugbank-id": "DB06272",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Maxacalcitol"
                    },
                    {
                        "drugbank-id": "DB06410",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Doxercalciferol"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Vitamin D"
                    },
                    {
                        "drugbank-id": "DB13097",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with 1alpha Hydroxyvitamin D5"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The serum concentration of Cefditoren can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Aluminum hydroxide can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ethambutol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The serum concentration of Levothyroxine can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01344",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The serum concentration of Cefpodoxime can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The serum concentration of Cefuroxime can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Aluminum hydroxide may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Aluminum hydroxide may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Aluminum hydroxide may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The serum concentration of Sotalol can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Sulpiride can be increased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The therapeutic efficacy of Allopurinol can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Fexofenadine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "Sodium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The serum concentration of Glycochenodeoxycholic Acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The serum concentration of Cholic Acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The serum concentration of Glycocholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The serum concentration of Deoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The serum concentration of Taurocholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The serum concentration of Obeticholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The serum concentration of Bamet UD2 can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08858",
                        "description": "The serum concentration of cis Diamminechlorocholylglycinateplatinum II can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The serum concentration of Dehydrocholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The serum concentration of Hyodeoxycholic Acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11860",
                        "description": "The serum concentration of Aramchol can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14016",
                        "description": "The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "The bioavailability of Cysteamine can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Periciazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of BL 1020 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Thiazinam resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dixyrazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Perphenazine enanthate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06799",
                        "description": "The therapeutic efficacy of Methenamine can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Technetium Tc 99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09267",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The serum concentration of Pamidronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The serum concentration of Alendronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The serum concentration of Ibandronate can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The serum concentration of Clodronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The serum concentration of Risedronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The serum concentration of Tiludronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The serum concentration of Incadronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The bioavailability of Betamethasone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The bioavailability of Fluticasone propionate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The bioavailability of Triamcinolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The bioavailability of Fludrocortisone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The bioavailability of Hydrocortisone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The bioavailability of Prednisolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The bioavailability of Methylprednisolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The bioavailability of Trilostane can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The bioavailability of Budesonide can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The bioavailability of Dexamethasone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The bioavailability of Cortisone acetate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The bioavailability of Paramethasone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The bioavailability of Aldosterone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The bioavailability of Fluprednidene can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The bioavailability of Fluprednisolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The bioavailability of Meprednisone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The bioavailability of Melengestrol can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The bioavailability of Deflazacort can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The bioavailability of Cortivazol can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The bioavailability of Prednylidene can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The bioavailability of Fluocortin can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The bioavailability of Fluperolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The bioavailability of Cloprednol can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The bioavailability of Fluclorolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The bioavailability of Hydrocortisone cypionate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The bioavailability of Prednisolone phosphate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The bioavailability of Prednisone acetate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The bioavailability of Clocortolone acetate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The bioavailability of Melengestrol acetate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The bioavailability of Betamethasone phosphate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The bioavailability of Cortisone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The bioavailability of Clobetasol propionate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The bioavailability of Fluocinonide can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The bioavailability of Mometasone furoate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The bioavailability of Ciclesonide can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The bioavailability of Desoximetasone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The bioavailability of Fluticasone furoate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The bioavailability of Fluocinolone acetonide can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The bioavailability of Fluocortolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The bioavailability of Beclomethasone dipropionate can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The bioavailability of Difluocortolone can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The serum concentration of Amphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The serum concentration of Phentermine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The serum concentration of Pseudoephedrine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The serum concentration of Benzphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The serum concentration of Diethylpropion can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The serum concentration of Lisdexamfetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The serum concentration of Mephentermine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The serum concentration of MMDA can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The serum concentration of Midomafetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylamphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The serum concentration of 4 Bromo 2 5 dimethoxyamphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The serum concentration of Tenamfetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The serum concentration of Chlorphentermine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The serum concentration of Methylenedioxyethamphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The serum concentration of Dextroamphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The serum concentration of Metamfetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The serum concentration of Iofetamine I 123 can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The serum concentration of Ritobegron can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The serum concentration of Mephedrone can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The serum concentration of Methoxyphenamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The serum concentration of Gepefrine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylthioamphetamine can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferrous bisglycinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00893",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01592",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02369",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of 3 Aza 2 3 Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02423",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02552",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04160",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05143",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of OXI 4503 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sodium phosphate monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11493",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13995",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14481",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14523",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "The serum concentration of Technetium Tc 99m oxidronate can be increased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The absorption of Imatinib can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Miconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06395",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06440",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Isavuconazonium resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12073",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Isavuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Ritonavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15623",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of TMC 310911 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The absorption of Palbociclib can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of adverse effects can be increased when Aluminum hydroxide is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The serum concentration of Propranolol can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Cefdinir can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen can cause a decrease in the absorption of Aluminum hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The bioavailability of Gabapentin can be decreased when combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}